A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Rod S Taylor, Anthony Muchai Manyara et al.|EClinicalMedicine|2023Cited by 60
Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registryRachel Black, Catherine Hill, Susan Lester et al.|Arthritis Research & Therapy|2017Cited by 50
Mortality estimates and excess mortality in rheumatoid arthritisRachel Black, Catherine Hill, Susanna Proudman et al.|Lara D. Veeken|2023Cited by 49
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|BMJ|2024Cited by 45
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|BMJ|2024Cited by 28